$VKTX: Consolidation In Viking Therapeutics Provides An Opportunity
Monday, October 2, 2023 2:18 PM EDT
Viking Therapeutics Inc. is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases. Metabolic and rare disease programs include novel selective thyroid receptor-β agonist approach.
In this article: VKTX